NASDAQ Companies

ZUG, Switzerland and BOSTON, Jan. 08, 2024 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative […]

Completed enrollment in Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease and expects […]

BOSTON and CHENGDU, China, Jan. 08, 2024 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on […]

PONTE VEDRA, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a […]

Company to host a fireside chat and investor meetings at the 26thAnnual ICR Conference in Orlando, FL Monday, January 8, […]

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company […]

Total Sales Increased 15.6%; Comparable Sales Increased 3.6% Reiterates Fourth Quarter and Full Year Fiscal 2023 Guidance, with Net Sales […]

Received 459 new patient start forms for FILSPARI®(sparsentan) in the fourth quarter of 2023; preliminary net product sales of FILSPARI […]

– Initial Data from the Ongoing Phase 2 Trial in Combination with the Antibody-Drug Conjugate (ADC) Sacituzumab Govitecan (SG) Suggest […]

SAN MATEO, Calif. and SINGAPORE, Jan. 08, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (NASDAQ: ASLN) (“ASLAN” or the “Company”), announced […]